LifeWallet Announces Second Quarter 2023 Financial Results
Recent Highlights
- LifeWallet continued to execute and advance its business strategy as the Paid Value of Potentially Recoverable Claims (“PVPRC”) increased by about
$1.8 billion for a total of$91.4 billion as ofJune 30, 2023 . Continued growth of PVPRC reflects strong demand for LifeWallet’s expertise and recovery services from health plans, providers, and self-insured entities. As a result of ongoing recovery efforts, a large portion of the newly acquired claims are incorporated into existing cases. - LifeWallet furthered its litigation and data-matching strategies during the quarter. The Company continues to make progress in its recovery efforts. Recoveries are dependent on the completion of litigation and the negotiation of settlements, the timing of which can be subject to the risk of delays associated with the litigation and settlement process. However, we continue to make progress in the data matching process associated with those settlement negotiations, whereby primary payer insurers reconcile what they owe as a result of detailed data exchanges.
- The Company had an Operating Loss of
$281.2 million and an Adjusted Operating Loss of$41.7 million for the six months ended onJune 30, 2023 , which is adjusted to exclude non-cash items such as claims amortization expenses, and an allowance for credit losses. - On
March 29, 2023 , the Company entered into the Working Capital Credit Facility consisting of commitments to fund up to$48 million in proceeds. This transaction highlights our investors’ continued confidence in the Company. - On
April 12, 2023 , the Company entered into the Virage MTA Amendment, which extended the due date for the payment obligations toVirage toSeptember 30, 2024 . - On
April 12, 2023 , the Company entered into an amended and restated promissory note with Nomura, which extended the due date toSeptember 30, 2024 . - Management implemented a reduction of operating costs in 2023 through the reduction or elimination of certain controllable expenses particularly within the budgeted costs to expand and develop new solutions through the LifeWallet platform, advertising expenses, and non-contingent legal fees. The Company anticipates that the reductions could contribute approximately
$19.7 million in savings to operating expenses over the next twelve months.
Second Quarter 2023 Financial Highlights
- Revenue: Total revenue for the three months and six months ended
June 30, 2023 , was$2.5 million and$6.03 million respectively. - Operating loss: Operating Loss for the three months and six months ended
June 30, 2023 , was$140.5 million , and$281.2 million respectively, compared with$67 million and$70.8 million three months and six months endedJune 30, 2022 respectively. Adjusted Operating Loss for three months and six months endedJune 30, 2023 was$19.5 million , and$41.7 million respectively excluding non-cash claims amortization expense of$121.0 million for the three months endedJune 30, 2023 and$234.5 million for the six months endedJune 30, 2023 .1 - Net loss: Net loss for the three months and six months ended
June 30, 2023 , was$210.8 million and$385 million respectively. Adjusted Net Loss for the three months endedJune 30, 2023 was$17.9 million , excluding the non-cash items. For the Six Months EndedJune 30, 2023 , Adjusted Net Loss was$33.4 million , excluding the non-cash items noted. 1 - Liquidity: As of
June 30, 2023 , cash and cash equivalents were$6.4 million . OnMarch 29, 2023 , the Company announced it entered into the Working Capital Credit Agreement consisting of a commitment to fund up to$48 million in proceeds from March of 2023 through August of 2024. In addition, the Company implemented a cost saving strategy which could contribute approximately$19.7 million in savings to operating expenses over the next twelve months.
(1) Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.
Assigned Recovery Rights Claims Paid and Billed Value
The table below outlines the Company's growth in claims data received in the most recent periods. The amounts represent data received from current and new assignors:
| Six Months Ended |
Year Ended |
Year Ended |
Year Ended |
|||||||||
| $ in billions | ||||||||||||
| Paid Amount | $ | 380.8 | $ | 374.8 | $ | 364.4 | $ | 58.4 | ||||
| Paid Value of Potentially Recoverable Claims | 91.4 | 89.6 | 86.6 | 14.7 | ||||||||
| Billed Value of Potentially Recoverable Claims | 386.6 | 377.8 | 363.2 | 52.3 | ||||||||
| Recovery Multiple | N/A(1) | N/A(1) | N/A(1) | N/A(1) | ||||||||
| Penetration Status of Portfolio | 86.8 | % | 85.8 | % | 75.6 | % | N/A | |||||
(1) During the six months ended
(2) On
- Total Paid Amount of owned claims has increased to
$380.8 billion , as ofJune 30, 2023 , up$6 billion or 1.5% from$374.8 billion as ofDecember 31, 2022 . This figure represents the amounts our clients/assignors have paid for in medical bills (including capitation payments). - Paid Value of Potential Recoverable Claims grew to
$91.4 billion , as ofJune 30, 2023 , up$1.8 billion from$89.6 billion as ofDecember 31, 2022 . This figure represents the amounts LifeWallet estimates are potentially recoverable as identified by LifeWallet algorithms.
Recoveries Being Sought by Category:
The table below outlines specific dollar amounts identified by the Company, broken down by litigation and demand letter type, that it plans to pursue against different responsible parties:
| Recoveries Being Sought By Category(1) | ||||||||||
| As of |
Paid Amount ($ in millions) |
Billed Amounts Sought ($ in millions) |
2023 Recovery ($ in thousands) |
Recovery Multiple | ||||||
| ACCIDENT RELATED: | ||||||||||
| Data Matching(2) | 2.4x | |||||||||
| Demand Letters(3) | ||||||||||
| 1st Party Demands | 4.5x | |||||||||
| 3rd Party Demands | 5.7x | |||||||||
| Case and Lien Recoveries | 0.9x | |||||||||
| FRAUD & MISCONDUCT CASES: | ||||||||||
| Private Lien Resolution Program(4) | 19.2x | |||||||||
| Big Pharma/Product Liability(5)(6) | 0.8x | |||||||||
| Group Health Plan Recovery(5) | ||||||||||
(1) LIFW during 2022 announced a strategy whereby the Company is sending out individual demand letters on identified recoverable claims to responsible payers for prompt payment. We expect this strategy could result in more predictable revenues. The table above outlines specific dollar amounts identified by the Company, broken down by litigation and demand letter type, that it plans to pursue against different responsible parties. The results for this quarter are not significant from the total amount recovered, therefore, the recovery multiple should not be considered indicative of future results. The overall recovery for the six months ended
(2) Data Matching represents potential recovery opportunities the Company has identified via court orders or agreements with primary payers.
(3) As previously announced, MSP initiated billing amounts to primary payers (i.e., property and casualty insurers), giving these parties the opportunity to pay without the need for litigation or extended litigation.
(4) PLRPs are established to resolve health care liens asserted by private health insurance providers in mass tort settlements. LIFW is actively working with various lien resolution administrators to recover on those owned claims for which manufacturers have already settled other lawsuits and established PLPRs.
(5)
(6) Paid Amount submission to lien resolution company. Settlement multiple may vary.
Data Matching: Data Matching represents potential recovery opportunities the Company has identified via court orders or agreements with primary payers. These represent potential recoveries that LifeWallet could receive from a portion of settlement discussions with approximately 28% of the
Demand Letters: As previously announced, LifeWallet initiated billing amounts to primary payers (i.e., property and casualty insurers) and big pharma, giving these parties the opportunity to pay without the need for litigation or extended litigation. For Q3 2023, our recovery multiple on 1st party & 3rd party demand letters, was 4.5x and 5.7x, respectively. The results for this quarter are not significant from the total amount recovered, therefore, the recovery multiple should not be considered indicative of future results. The overall recovery for the six months ended
Private Lien Resolution Programs (“PLPR”): PLRPs are established to resolve health care liens asserted by private health insurance providers in mass tort settlements. LifeWallet is actively working with various lien resolution administrators to recover on those owned claims for which manufacturers have already settled other lawsuits and established PLRPs.
Financial Outlook
Recoveries Guidance: The Company continues to make progress in its recovery efforts, and management continues to believe such projected recoveries are ultimately collectible. Recoveries are dependent on the completion of litigation and the negotiation of settlements, which are inherently uncertain and are subject to risk of delay and litigation outcomes. As a result, the Company will not provide future guidance on recoveries that are dependent on litigation or subrogation process.
Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.
Nasdaq Compliance
Based on the
The Company intends to actively monitor its bid price and will consider available options to resolve the deficiency and regain compliance with the Nasdaq Listing Rule 5450(a)(1) including by effecting a reverse stock split, if necessary.
About LifeWallet
In
Founded in 2014, LifeWallet has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. The Company provides the healthcare industry with comprehensive compliance solutions, while innovating technologies to help save lives. For more information, visit:
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, including for example guidance for 2022 portfolio recovery and total gross recoverables. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance or results and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by MSP Recovery herein speaks only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for MSPR to predict or identify all such events or how they may affect it. MSPR has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, MSPR’s ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; the inherent uncertainty surrounding settlement negotiations and/or litigation, including with respect to both the amount and timing of any such results; the validity of the assignments of claims to MSPR; the ability to successfully expand the scope of MSPR’s claims or obtain new data and claims from MSPR’s existing assignor base or otherwise; MSPR’s ability to innovate and develop new solutions, and whether those solutions will be adopted by MSPR’s existing and potential assignors; negative publicity concerning healthcare data analytics and payment accuracy; and those other factors included in MSPR’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by it with the
MSP RECOVERY, INC. and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
| (In thousands except per share amounts) | 2023 | 2022 | ||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 6,433 | $ | 3,661 | ||||
| Restricted cash | — | 11,420 | ||||||
| Accounts receivable | 4,610 | 6,195 | ||||||
| Affiliate receivable (1) | 832 | 2,425 | ||||||
| Prepaid expenses and other current assets (1) | 19,360 | 27,656 | ||||||
| Total current assets | 31,235 | 51,357 | ||||||
| Property, plant and equipment, net | 4,712 | 3,432 | ||||||
| Intangible assets, net (2) | 3,374,615 | 3,363,156 | ||||||
| Total assets | $ | 3,410,562 | $ | 3,417,945 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 7,260 | $ | 8,422 | ||||
| Affiliate payable (1) | 19,822 | 19,822 | ||||||
| Commission payable | 802 | 545 | ||||||
| Derivative liability | — | 9,613 | ||||||
| Warrant liability | 1,012 | 5,311 | ||||||
| Other current liabilities | 77,726 | 72,002 | ||||||
| Total current liabilities | 106,622 | 115,715 | ||||||
| Guaranty obligation (1) | 862,219 | 787,945 | ||||||
| Claims financing obligation and notes payable (1) | 485,060 | 198,489 | ||||||
| Loan from related parties (1) | 130,709 | 125,759 | ||||||
| Interest payable (1) | 22,467 | 2,765 | ||||||
| Total liabilities | $ | 1,607,077 | $ | 1,230,673 | ||||
| Commitments and contingencies (Note 12) | ||||||||
| Class A common stock subject to possible redemption, 1,129,589 shares at redemption value as of |
— | 1,807 | ||||||
| Stockholders’ Equity (Deficit): | ||||||||
| Class A common stock, |
$ | 13 | $ | 7 | ||||
| Class V common stock, |
311 | 315 | ||||||
| Additional paid-in capital | 176,331 | 136,760 | ||||||
| Members’ equity | - | - | ||||||
| Accumulated deficit | (42,339 | ) | (29,203 | ) | ||||
| Total Stockholders’ Equity (Deficit) | 134,316 | 107,879 | ||||||
| Non-controlling interest | 1,669,169 | 2,077,586 | ||||||
| Total equity | $ | 1,803,485 | $ | 2,185,465 | ||||
| Total liabilities and equity | $ | 3,410,562 | $ | 3,417,945 | ||||
- As of
June 30, 2023 andDecember 31, 2022 , the total affiliate receivable, affiliate payable, guaranty obligation and loan from related parties balances are with related parties. In addition, the prepaid expenses and other current assets, claims financing obligation and notes payable, and interest payable includes balances with related parties. See Note 13, Related Party Transactions, for further details. - As of
June 30, 2023 andDecember 31, 2022 , intangible assets, net included$2.4 billion and$2.3 billion , respectively, related to a consolidated VIE. See Note 9, Variable Interest Entities, for further details.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
MSP RECOVERY, INC. and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
| Three months ended |
Six months ended |
|||||||||||||||
| (In thousands except per share amounts) | 2023 | 2022 | 2023 | 2022 | ||||||||||||
| As Restated | As Restated | |||||||||||||||
| Claims recovery income | $ | 2,542 | $ | 1,357 | $ | 6,039 | $ | 1,466 | ||||||||
| Claims recovery service income (1) | — | 3,971 | 498 | 12,047 | ||||||||||||
| Total Claims Recovery | $ | 2,542 | $ | 5,328 | $ | 6,537 | $ | 13,513 | ||||||||
| Operating expenses | ||||||||||||||||
| Cost of claim recoveries (2) | 377 | 702 | 1,398 | 709 | ||||||||||||
| Claims amortization expense | 121,004 | 38,991 | 234,473 | 41,708 | ||||||||||||
| General and administrative (3) | 7,706 | 5,982 | 14,561 | 10,428 | ||||||||||||
| Professional fees | 3,417 | 3,131 | 13,145 | 5,069 | ||||||||||||
| Professional fees – legal (4) | 10,467 | 23,765 | 19,018 | 26,237 | ||||||||||||
| Allowance for credit losses | — | — | 5,000 | — | ||||||||||||
| Depreciation and amortization | 88 | 72 | 97 | 151 | ||||||||||||
| Total operating expenses | 143,059 | 72,643 | 287,692 | 84,302 | ||||||||||||
| Operating Loss | $ | (140,517 | ) | $ | (67,315 | ) | $ | (281,155 | ) | $ | (70,789 | ) | ||||
| Interest expense (5) | (73,618 | ) | (24,352 | ) | (116,008 | ) | (34,767 | ) | ||||||||
| Other income, net | 1,662 | 39 | 8,289 | 37 | ||||||||||||
| Change in fair value of warrant and derivative liabilities | 1,644 | (14,353 | ) | 3,899 | (14,353 | ) | ||||||||||
| Net loss before provision for income taxes | $ | (210,829 | ) | $ | (105,981 | ) | $ | (384,975 | ) | $ | (119,872 | ) | ||||
| Provision for income tax expense | - | — | — | — | ||||||||||||
| Net loss | $ | (210,829 | ) | $ | (105,981 | ) | $ | (384,975 | ) | $ | (119,872 | ) | ||||
| Less: Net loss attributable to non-controlling members | 202,609 | 104,101 | 371,839 | 117,992 | ||||||||||||
| Net loss attributable to controlling members | $ | (8,220 | ) | $ | (1,880 | ) | $ | (13,136 | ) | $ | (1,880 | ) | ||||
| Basic and diluted weighted average shares outstanding, Class A Common Stock | 123,564,802 | 13,607,255 | 106,183,727 | 13,607,255 | ||||||||||||
| Basic and diluted net loss per share, Class A Common Stock | $ | (0.07 | ) | $ | (0.14 | ) | $ | (0.12 | ) | $ | (0.14 | ) | ||||
(1) For the three and six months ended
(2) For the three and six months ended
(3) For the three and six months ended
(4) For the three and six months ended
(5) For three and six months ended
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Non-GAAP Financial Measures
MSP RECOVERY, INC. and Subsidiaries
Non-GAAP Reconciliation
| Three Months Ended |
Six Months Ended |
|||||||||||||||
| (In thousands) | 2023 | 2022 | 2023 | 2022 | ||||||||||||
| GAAP Operating Loss | $ | (140,517 | ) | $ | (67,315 | ) | $ | (281,155 | ) | $ | (70,789 | ) | ||||
| Share-based compensation | — | 20,055 | — | 20,055 | ||||||||||||
| Claims amortization expense | 121,004 | 38,991 | 234,473 | 41,708 | ||||||||||||
| Allowance for credit losses | — | — | 5,000 | — | ||||||||||||
| Adjusted operating loss | $ | (19,513 | ) | $ | (8,269 | ) | $ | (41,682 | ) | $ | (9,026 | ) | ||||
| GAAP Net Loss | $ | (210,829 | ) | $ | (105,981 | ) | $ | (384,975 | ) | $ | (119,872 | ) | ||||
| Share-based compensation | — | 20,055 | — | 20,055 | ||||||||||||
| Claims amortization expense | 121,004 | 38,991 | 234,473 | 41,708 | ||||||||||||
| Allowance for credit losses | — | — | 5,000 | — | ||||||||||||
| Paid-in-kind Interest | 73,618 | 24,352 | 115,996 | 34,744 | ||||||||||||
| Change in fair value of warrant and derivative liabilities | (1,644 | ) | 14,353 | (3,899 | ) | 14,353 | ||||||||||
| Adjusted net loss | $ | (17,851 | ) | $ | (8,230 | ) | $ | (33,405 | ) | $ | (9,012 | ) | ||||
In addition to the financial measures prepared in accordance with GAAP, this Form 10-Q also contains non-GAAP financial measures. We consider “adjusted net loss” and “adjusted operating loss” as non-GAAP financial measures and important indicators of performance and useful metrics for management and investors to evaluate our business’s ongoing operating performance on a consistent basis across reporting periods. We believe these measures provide useful information to investors. Adjusted net loss represents Net loss adjusted for certain non-cash and non-recurring expenses and adjusted operating loss items represents Operating loss adjusted for certain non-cash and non-recurring expenses. A reconciliation of these non-GAAP measures to their most relevant GAAP measure is included in Management's Discussion and Analysis in the Form 10-Q.
For Investors:
For Media:
[email protected]
Source: LifeWallet
Double-digit health insurance rate increases coming for some WNY small group, individual plans [The Buffalo News, N.Y.]
AM Best Revises Issuer Credit Rating Outlook to Positive; Affirms Credit Ratings of BTG Pactual Resseguradora S.A.
Advisor News
- Living longer, retiring poorer: Why fragmented systems are failing Americans
- Women say their advisors respect them, but talk down to them
- How PEPs compare with traditional 401(k)s
- Allianz studies why 42% of Americans retire sooner than expected
- Why advisors should be talking about life settlements
More Advisor NewsAnnuity News
- Jackson Introduces Dow Jones Industrial Average Index Option, Flexible Premiums, Six-Year Rate Guarantee in Latest Registered Index-Linked Annuity Launch
- Senior Market Sales® Fortifies Annuity Reach With Acquisition of Retirement Planning Firm Stratton & Company
- NAIC regulators continue pushing for annuity illustration updates
- Wink: Flat first-quarter annuity sales fall just short of $100B
- 26North Re Agrees to Acquire 100% of Independent Insurance Group
More Annuity NewsHealth/Employee Benefits News
- Cigna to pull out of individual health market, affecting thousands in Colorado
- Researchers from Maccabi Healthcare Services Report New Studies and Findings in the Area of Hepatitis C Virus (Implementation of a Hepatitis C Screening Program for At-Risk Former Soviet-Bloc Immigrants in a Large Health Maintenance Organization): Liver Diseases and Conditions – Hepatitis C Virus
- More than 40,000 Coloradans will need a new health insurance carrier next year. Here's who is affected.
- Some retired NC state workers will pay more for health insurance. Working enrollees could save.
- Cuts coming to Kentucky Medicaid program, social services and more
More Health/Employee Benefits NewsLife Insurance News
- KBRA Releases Research – Private Credit: A More Balanced Review of the NAIC PLR Review Process for Insurance Balance Sheets
- Jackson Introduces Dow Jones Industrial Average Index Option, Flexible Premiums, Six-Year Rate Guarantee in Latest Registered Index-Linked Annuity Launch
- State locates $107M in missing insurance funds
- The opportunity in the bottom half of the K-shaped economy
- AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries
More Life Insurance News